Introduction
The advancement in medical technology has prolonged the longevity of people suffering from chronic renal insufficiency (1) . Despite all these improvements, the patients are still affected by the physiological stressors due to the nature of disease as well as therapeutic maintenance such as hemodialysis. Among physiological stressors, it can be pointed to pain during and after hemodialysis (2) . Regarding the necessity of continuously using arterial and venous needles for access to vessels in hemodialysis (3), these patients experience at least 300 needle-related pain each year (4) . Pain is an unpleasant sensation and an emotional experience that is associated with potential or actual tissue damage and is one of the unpleasant complications in dialysis patients (5) . Pain not only results from the nature of the disease, but may also be derived from many invasive diagnostic and therapeutic procedures (6) . Diagnostic treatments are among the most stressful medical events (7) . Studies have shown that about 3.5% of adult patients are very scared and 22% have a moderate fear of needles. The pain caused by the insertion of needles and catheters into blood vessels becomes problematic when it is repeated and requires constant use of them. In the treatment of patients with chronic renal failure, hemodialysis as a preservative usually requires continuous use of arterial and venous needles for the patient (8).
Many improvements have been recently made in the treatment of pain, since several pharmaceutical and noninvasive methods have been proposed to relieve pain. However, in some cases, the effect of these methods on the pain reduction of patients is questionable (9) . Moreover, due to the side effects of drugs, the use of non-medicated methods for controlling and relieving pain is in progress today. One of these non-pharmacological methods is the use of cooling sprays (10) . Due to the immediate relief of pain in athletes following the use of cooling sprays (11, 12) , it seems that they can be used to reduce the pain caused by needling among hemodialysis patients.
Objectives
The present study aimed to assess the pain relieving effects and complications of cooling sprays among patients undergoing hemodialysis.
Patients and Methods

Patients
This randomized double-blinded controlled trial on patients aged higher than 18 years who suffering hemodialysis admitted to two great referral hospitals in Tehran, Iran (2018). The exclusion criteria were unwillingness to participate in the study, sensitivity to alcoholic beverages, pregnancy, the use of analgesics within 24 hours prior to needling, the presence of mental problems and inability to fill questionnaire and collaboration, non-persistent hemodialysis, cooperation in another study, skin reaction at the pinching site, or anesthetizing organs with vascular access. The eligible patients were randomly (using the random allocation version 1.2 software) assigned into two groups, including the group received cooling spray for relieving pain (as the intervention group, n = 40) and the group did not receive this relieving pain method (as the control group, n = 40). In the intervention group and in a hemodialysis session, two puffs of the Cramer Cold Spray were sprayed 30 seconds before the cavitation. After 30 seconds, the cannulation was performed and the questionnaire was fulfilled again. The contents of the cooling spray include butane, isobutane, propane, perfume, and limonene. In the control group, distilled water was administered as placebo. The pain severity was assessed by the visual analogue scale (VAS) method scored as 0 for the mildest pain and 10 for the most severe pain. Figure 1 shows the CONSORT of the study.
Ethical issues
The research followed the tents of the Declaration of Helsinki. The Ethics Committee of Iran University of Medical Sciences approved this study (RHC.AC.IR. 
Data analysis
Patients' demographic information was collected using a checklist and by reviewing the hospital recorded files. Descriptive analysis was used to describe the data, including mean ± standard deviation (SD) for quantitative variables and frequency (percentage) for categorical variables. Chi-square test, t test, or Mann-Whitney U test were applied for comparison of variables. For the statistical analysis, the statistical software IBM SPSS Statistics for Windows version 22.0 (IBM Corp. Released 2013, Armonk, New York) was used. P values <0.05 were considered statistically significant.
Results
Baseline characteristics in the intervention and control groups are summarized in Table 1 . Comparing characteristics across the two groups showed no difference in gender, age, body mass index (BMI), educational level, job status, medical history including smoking, diabetes mellitus and hypertension, reasons for renal failure as well as the duration of dialysis and cannulation. As shown in Table 2 , the mean of pain severity score was not different between the intervention and control group before intervention, however the patients in the intervention group experienced milder pain due to cannulation as compared to control group (3.28 ± 1.13 versus 5.30 ± 1.76; P < 0.001). Interviewing with the patients receiving cooling spray showed willingness to the use of spray in the following experiences in 87.5%. The local complication due to the use of cold spray was revealed only in 5% of patients.
Discussion
The aim of this study was to investigate the effect of cold spray on pain induced by needle entry in hemodialysis patients. In this study, the pain scores of patients in the intervention group were compared with the control group. The results showed that the administration of cooling spray reduces the pain induced by needle entry in hemodialysis patients, which was statistically significant between the two groups. The researcher's hypothesis that the use of cold spray has been effective in reducing pain was successfully confirmed. Different methods have been used to reduce the pain caused by needle entry in such patients. In a study by Fangin et al (13) , the use of cryotherapy is effective in reducing pain in the patient, which is consistent with the results of this study. In another study by Hassan et al (14) , using cryotherapy could reduce the pain of fistula catheterization in children under hemodialysis. Our current hypothesis came from the fact that cooling sprays have been very effective on athletes with acute injuries during sporting events. Also, some experiments could demonstrate the efficacy of cooling on pain caused by needling in clinical settings. Likewise, in a study by Griffith et al (15) , the administration of a vapocoolant immediately before intravenous cannulation reduced pain as well as discomfort during the procedure. Accordingly, in a study by Hijazi et al in 2009 (16) , topical alkane vapocoolant spray is effective, acceptable, and safe in reducing pain with peripheral intravenous cannulation in adults in the emergency department. The studies on the impact of vapocoolant sprays for relieving pain with intravenous cannulation have revealed inconsistent results. Some studies showed ethyl-chloride to be effective (17, 18) , while two others found ethylchloride and fluorohydrocarbon (19, 20) respectively, to be ineffective. In a systematic review, Hogan et al, concluded; "vapocoolants were ineffective in children and adults when compared to placebo, and effective in adults only when compared to no treatment" (21) . These contradictory results could be related to the variations in cannula size, duration and distance of spray, small sample sizes, and lack of blinding. In our trial, we used spray including butane, isobutane, propane, perfume, and limonene that seems to be very effective in our trial especially in our patients that suffering repeated vascular cannulation. Today, most hemodialysis patients prefer nonpharmacological methods for pain relief. Using the cryotherapy technique reduces the temperature in the painful area and inflammation, which reduces the intensity and duration of nerve conduction (22) . The use of cooling to relieve pain has been employed since Hippocrates in the fourth century BC (23) . Cooling the tissue also induce vasoconstriction, which may decrease swelling and ecchymosis (24) . In this regard, the American Society for Dermatologic Surgery guidelines now recommends pre-injection use of ice or cooling devices (25) . However, it should be noted that considering some confounding factors such as duration of using spray, the number of cannulation, different chemical contents of sprays and disease duration as well as psychological background of patients is necessary to achieve perfect and reliable results. Considering the need for frequent venopuncture in hemodialysis patients, evaluation of the effect and adverse events of this method is necessary.
Conclusion
In general, the findings of this study showed that the administration of cooling spray in hemodialysis patients can reduce the pain caused by needle insertion without causing serious complications. These results can be used as an independent intervention to dialysis nurses to manage pain in the patients. Additionally, this method can normally be used as a non-pharmacological relief method to reduce pain in hemodialysis patients.
Limitations of the study
Our limitations were the small sample size and short duration of the intervention.
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